For example, quantitative assessment of methylation in CIMP-specific promoters of MLH1, WRN, and other DNA-repair genes in colon tumors, in comparison to paired normal tissues, may predict response to treatment [2]. The gene discussed is MLH1; the disease is colonic neoplasm.